HighTower Advisors, LLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$30,000
+66.7%
38,000
+111.1%
0.00%
Q2 2022$18,0000.0%18,0000.0%0.00%
Q1 2022$18,0000.0%18,0000.0%0.00%
Q4 2021$18,000
+20.0%
18,000
+20.0%
0.00%
Q3 2021$15,0000.0%15,0000.0%0.00%
Q2 2021$15,0000.0%15,0000.0%0.00%
Q1 2021$15,0000.0%15,0000.0%0.00%
Q4 2020$15,0000.0%15,0000.0%0.00%
Q3 2020$15,0000.0%15,0000.0%0.00%
Q2 2020$15,0000.0%15,0000.0%0.00%
Q1 2020$15,0000.0%15,0000.0%0.00%
Q4 2019$15,000
+7.1%
15,0000.0%0.00%
Q3 2019$14,0000.0%15,0000.0%0.00%
Q2 2019$14,000
-6.7%
15,0000.0%0.00%
Q1 2019$15,000
+7.1%
15,0000.0%0.00%
Q4 2018$14,000
-6.7%
15,0000.0%0.00%
Q3 2018$15,0000.0%15,0000.0%0.00%
Q2 2018$15,000
-16.7%
15,000
-21.1%
0.00%
Q1 2018$18,0000.0%19,0000.0%0.00%
Q4 2017$18,0000.0%19,0000.0%0.00%
Q3 2017$18,000
-5.3%
19,0000.0%0.00%
Q2 2017$19,0000.0%19,0000.0%0.00%
Q1 2017$19,000
-5.0%
19,0000.0%0.00%
Q4 2016$20,000
-13.0%
19,0000.0%0.00%
Q3 2016$23,000
-8.0%
19,0000.0%0.00%
Q2 2016$25,0000.0%19,0000.0%0.00%
Q1 2016$25,000
-39.0%
19,000
-26.9%
0.00%
Q4 2015$41,000
+64.0%
26,000
+36.8%
0.00%
Q3 2015$25,000
-7.4%
19,0000.0%0.00%
Q2 2015$27,000
-3.6%
19,0000.0%0.00%
Q1 2015$28,000
+7.7%
19,0000.0%0.00%
Q4 2014$26,000
+8.3%
19,0000.0%0.00%
Q3 2014$24,0000.0%19,0000.0%0.00%
Q2 2014$24,0000.0%19,0000.0%0.00%
Q1 2014$24,000
-36.8%
19,000
-47.2%
0.00%
-100.0%
Q4 2013$38,000
+90.0%
36,000
+89.5%
0.00%0.0%
Q3 2013$20,0000.0%19,0000.0%0.00%0.0%
Q2 2013$20,00019,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2020
NameSharesValueWeighting ↓
Arena Capital Advisors, LLC- CA 68,443,000$68,785,00010.97%
PIPER SANDLER & CO. 12,550,000$12,425,0008.95%
Radcliffe Capital Management, L.P. 100,783,000$100,279,0006.28%
INCOME RESEARCH & MANAGEMENT 14,775,000$14,701,0005.39%
PenderFund Capital Management Ltd. 4,000,000$5,123,0001.30%
Bracebridge Capital, LLC 5,500,000$5,390,0000.82%
Western Asset Management Company, LLC 9,000,000$8,916,0000.57%
WESTWOOD HOLDINGS GROUP INC 43,125,000$42,856,0000.49%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,050,000$1,045,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,675,0000.35%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders